Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 11Rectal Neoplasms 5Stomach Neoplasms 4Neoplasms 1Neoplasm Metastasis 1Locally Advanced Rectal Cancer 1Esophageal Neoplasms 1Colonic Neoplasms 1Colonic Diseases 1Adenocarcinoma of the Lower Rectum 1

Interventions

trimebutine 3-thiocarbamoylbenzenesulfonate 2pembrolizumab 2Oxaliplatin 2Cyclophosphamide 2pralsetinib 1napabucasin 1ibrutinib 1guadecitabine 1XELOX 1Sutures 1Surgical Instruments 1Polyethylene Glycols 1Optical Imaging 1Ocoxin 1Leucovorin 1Irinotecan 1Fluorouracil 1Control Groups 1Colonoscopy 1Cetuximab 1Capecitabine 1Bevacizumab 1Ascorbic Acid 15-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Colonic Diseases × XELOX × Clear all
NCT00250029 2011-09-27

Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen

New Mexico Cancer Research Alliance

Phase NA Completed
30 enrolled
Gastrointestinal

Colonic Diseases, Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡